Changing Treatment Strategy for Gastrinoma in Patients with Zollinger‐Ellison Syndrome
- 13 December 2005
- journal article
- review article
- Published by Wiley in World Journal of Surgery
- Vol. 30 (1) , 1-11
- https://doi.org/10.1007/s00268-005-0341-1
Abstract
We overviewed the recent development of curative surgery for gastrinoma that has been rapidly improved since the development of new localization techniques, especially the selective arterial secretagogue injection test (SASI test) and somatostatin receptor scintigraphy (SRS). A number of new pathological findings of gastrinomas in patients with Zollinger-Ellison syndrome have been accumulated in accordance with the increase of curative resection of gastrinomas, and these new findings also have contributed to the progress of the treatment strategy for grastrinomas.Keywords
This publication has 41 references indexed in Scilit:
- Management and Outcome of Patients With Sporadic Gastrinoma Arising in the DuodenumAnnals of Surgery, 2003
- Achieving Eugastrinaemia in Zollinger-Ellison Syndrome: Resection or Enucleation?Digestive Surgery, 2001
- Clinicopathological characteristics of duodenal microgastrinomasWorld Journal of Surgery, 1992
- Pancreatic Endocrine Tumors — The Search Goes OnNew England Journal of Medicine, 1992
- Curative Resection of Multiple Gastrinomas Aided by Selective Arterial Secretin Injection Test and Intraoperative Secretin TestAnnals of Surgery, 1989
- Microgastrinomas of the DuodenumAnnals of Surgery, 1989
- Outcome of Lymph Node Involvement in Patients with the Zollinger-Ellison SyndromeAnnals of Surgery, 1988
- Usefulness of Selective Arterial Secretin Injection Test for Localization of Gastrinoma in the Zollinger-Ellison SyndromeAnnals of Surgery, 1987
- Gastrin release from gastrinoma cells stimulated with secretinDigestive Diseases and Sciences, 1982
- Ulcerogenic Tumors of the Duodenum*Annals of Surgery, 1961